Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals

Endocrinology

Volumn 138, Issue 7, 1997, Pages 2979-2988

  Espositot, Diana L ^a   Blakesley, Vicky A ^a   Koval, Anatolii P ^a   Scrimgeour, Angus G ^a   Leroith, Derek ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE; PHENYLALANINE; SOMATOMEDIN C RECEPTOR; TYROSINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; GROWTH RATE; MITOGENESIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3 CELLS; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; HISTIDINE; HUMANS; MICE; MITOSIS; PHENYLALANINE; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-CRK; RECEPTOR, IGF TYPE 1; SRC HOMOLOGY DOMAINS; STRUCTURE-ACTIVITY RELATIONSHIP; TYROSINE;

EID: 0030999592     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.138.7.2979     Document Type: Article

References (45)

1. Yarden Y, Ullrich A 1988 Growth factor receptor tyrosine kinases. Annu Rev Biochem 57:443-478
2. LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT1995 Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
3. Ullrich A, Gray A, Ram AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, Jacobs S, Francke U, Ramachandran J, Fujita-Yamaguchi Y 19S6 Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J 5:2503-2512
4. LeRoith D, Adamo M, Werner H, Roberts Jr CT 1991 Insulin-like growth factors and their receptors as growth regulators in normal physiology and pathological states. Trends Endocrinol Metab 2:134-139
5. Backer JM, Myers JrMG, Sun S, Chin DJ, Shoelson SE, Miralpeix M, White MF 1993 Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3'-kinase. Formation of binary and ternary signaling complexes in intact cells. J Biol Chem 268:8204-8212
6. Lamphere L, Carpenter CL, Sheng ZF, Kallen RG, Lienhard GE 1994 Activation of PI 3-kinase in 3T3-L1 adipocytes by association with insulin receptor substrate-1. Am J Physiol 266:E486-E494
7. Baltensperger K, Kozma LM, Jaspers SR, Czech MP 1994 Regulation by insulin of phosphatidylinositol 3'-kinase bound to alpha- and beta-isoforms of p85 regulatory subunit. J Biol Chem 269:28937-28946
8. Yonezawa K, Ueda H, Hara K, Nishida K, Ando A, Chavanieu A, Matsuba H, Shii K, Yokono K, Fukui Y, Calas B, Grigorescu F, Dhand R, Gout I, Otsu M, Waterfield MD, Kasuga M1992 Insulin-dependent formation of a complex containing an 85-kDa subunit of phosphatidylinositol 3-kinase and tyrosinephosphorylated insulin receptor substrate 1. J Biol Chem 267:25958-25965
9. Cheatham B, Vlahos CJ, Cheatham L, Wang L, Blenis J, Kahn CR 1994 Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14:4902-4911
10. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M 1994 Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem 269:3568-3573
11. Skolnik EY, Batzer A, Li N, Lee C-H, Lowenstein E, Mohammadi M, Margolis B, Schlessinger J 1993 The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260:1953-1955
12. Tobe K, Matuoka K, Tamemoto H, Ueki K, Kaburagi Y, Asai S, Noguchi T, Matsuda M, Tanaka S, Hattori S, Fukui Y, Akanuma Y, Yazaki Y, Takenawa T, Kadowaki T 1993 Insulin stimulates association of insulin receptor sub-strate-1 with the protein abundant Src homology/growth factor receptorbound protein 2. J Biol Chem 268:11167-11171
13. Baltensperger K, Kozma LM, Cherniack AD, Klarlund JK, Chawla A, Banerjee U, Czech MP 1993 Binding of the ras activator son of sevenless to insulin receptor substrate-1 signaling complexes. Science 260:1950-1932
14. Sugimoto S, Wandless TJ, Shoelson SE, Neel BG, Walsh CT1994 Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1. J Biol Chem 269:13614-13622
15. Kühne MR, Pawson T, Lienhard GE, Feng G-S 1993 The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J Biol Chem 268:11479-11481
16. Pronk GJ, McGlade J, Pelicci G, Pawson T, Bös JL 1993 Insulin-induced phoshorylation of the 46- and 52-kDa She proteins. J Biol Chem 268:5748-5753
17. Sung CK, Sanchez-Margalet V, Goldfine ID 1994 Role of p85 subunit of phosphatidylinositol-3-kinase as an adaptor molecule linking the insulin receptor, p62, and GTPase-activating protein. J Biol Chem 269:12503-12507
18. Lavan BE, Lienhard GE 1993 The insulin-elicited 60-kDa phosphotyrosine protein in rat adipocytes is associated with phosphatidylinositol 3-kinase. J Biol Chem 268:5921-5928
19. Pons S, Asano T, Glasheen E, Miralpeix M, Zhang Y, Fisher TL, Myers Jr MG, Sun XJ, White MF 1995 The structure and function of p55r'K reveal a new regulatory subunit for phosphatidylinositol 3-kinase. Mol Cell Biol 15:4453-4465
20. Beitner-Johnson D, LeRoith D 1995 Insulin-like growth factor-I stimulates tyrosine phosphorylation of endogenous c-Crk. J Biol Chem 270:5187-5190
21. Miura M, Surmacz E, Burgaud J-L, Baserga R 1995 Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor. J Biol Chem 270:22639-22644
22. Blakesley VA, Kalebic T, Helman LJ, Stannard B, Faria TN, Roberts Jr CT, LeRoith D 1996 Tumorigenic and milogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250,1251, and 1316 in the carboxy-lerminus of the IGF-I receptor. Endocrinology 137:410-417
23. Kalo H, Faria TN, Stannard B, Roberts Jr CT, LeRoith D1993 Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor: characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (aIR-3). J Biol Chem 268:2655-2661
24. Higuchi R 19S9 Using PCR to engineer DNA. In: Erlich HA (ed) PCR Technology. Principles and Applications for DNA Amplification. Stockton Press, New York, pp 61-70
25. Mosmann T 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
26. Denizot F, Lang R1986 Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271-277
27. Hemandez-Sanchez C, Blakesley VA, Kalebic T, Helman L, LeRoith D 1995 The role of the tyrosine kinase domain of the insulin-like growth factor-I receptor in intracellular signaling, cellular proliferation, and tumorigenesis. J Biol Chem 270:29176-29181
28. Bradford M 1976 A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
29. Seger R, Ahn NG, Posada J, Munar ES, Jensen AM, Cooper JA, Cobb MH, Krebs EG 1992 Purification and characterization of mitogen-activated protein kinase activator(s) from epidermal growth factor-stimulated A431 cells. J Biol Chem 267:14373-14381
30. Munson PJ, Rodbard D 1980 Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239
31. Gotlschalk WK, Lammers R, Ullrich A 1992 The carboxy terminal 110 amino acid portion of the insulin receptor is important for insulin signalling to pyruvate dehydrogenase. Biochem Biophys Res Commun 189:906-911
32. Tartare S, Mothe I, Kowalski-Chauvel A, Breittmayer J-P, Ballotti R, Van Obberghen E 1994 Signal transduction by a chimeric insulin-like growth factor-I (IGF-I) receptor having the carboxyl-terminal domain of the insulin receptor. J Biol Chem 269:11449-11455
33. Mothe I, Tartare S, Kowalski-Chauvel A, Kaliman P, Van Obberghen E, Ballotti R 1995 Tyrosine kinase activity of a chimeric insulin-like-growthfactor-1 receptor containing the insulin receptor C-tcrminal domain. Comparison with the tyrosine kinase activities of the insulin and insulin-like-growthfactor-1 receptors using a cell-free system. Eur J Biochem 228:842-848
34. Faria TN, Blakesley VA, Kato H, Stannard B, LeRoith D, Roberts Jr CT 1994 Role of the carboxyl-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function. J Biol Chem 269:13922-13928
35. Corley-Mastick C, Kato H, Roberts Jr CT, LeRoith D, Saltiel AR 1994 Insulin and insulin-like growth factor-I receptors similarly stimulate deoxyribonucleic acid synthesis despite differences in cellular protein tyrosine phoshorylation. Endocrinology 135:214-222
36. Liu D, Zong CS, Wang L-H 1993 Distinctive effects of the carboxyl-terminal sequence of the insulin-like growth factor I receptor on its signaling functions. J Virol 67:6835-6840
37. Kaliman P, Baron V, Gautier N, Van Obberghen E1992 Antipeptide antibody to the insulin-like growth factor-I receptor sequence 1232-1246 inhibits the receptor kinase activity. J Biol Chem 267:10645-10651
38. Baron V, Gautier N, Komoniya A, Hainan HP, Scimeca J-C, Mervic M, Lavialle S, Dolais-Kitagbi J, Van Obberghen E 1990 Insulin binding to its receptor induces a conformational change in the receptor C-terminus. Biochemistry 29:4634-4641
39. Baron V, Gautier N, Kaliman P, Dolais-Kitabgi J, Van Obberghen E1991 The carboxy-terminal domain of the insulin receptor: its potential role in growthpromoting effects. Biochemistry 30:9365-9370
40. Levy-Toledano R, Accili D, Taylor SI 1993 Deletion of C-terminal 113 amino acids impairs processing and internalization of human insulin receptor: comparison of receptors expressed in CHO and NIH-3T3 cells. Biochim Biophys Acta 1220:1-14
41. Ellis L, Clauser E, Morgan DO, Edery M, Roth RA, Rutter WJ 1986 Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulinstimulated kinase activity and uptake of 2-deoxygIucose. Cell 45:721-732
42. Yamamoto-Honda R, Kadowaki T, Momomura K, Tobe K, Tamori Y, Shibasaki Y, Mori Y, Kaburagi Y, Koshio O, Akanuma Y, Yazaki Y, Kasuga M 1993 Normal insulin receptor substrate-1 phosphorylation in autophosphorylation-defective truncated insulin receptor. Evidence that phosphorylation of substrates might bo sufficient for certain biological effects evoked by insulin. J Biol Chem 268:16859-16865
43. Craparo A, O'Neill TJ, Gustafson TA 1995 Non-SH2 domains within insulin receptor substrate-1 and SHC mediate their phosphotyrosine-dependent interaction with the NPEY motif of the insulin-like growth factor I receptor. J Biol Chem 270:15639-15643
44. Lamothe B, Bucchini D, Jami J, Joshi RL 1995 Interaction of p85 subunit of PI 3-kinase with insulin and IGF-1 receptors analysed by using the two-hybrid system. FEBS Lett 373:51-55
45. Beitner-Johnson D, Blakesley VA, Shen-Orr Z, Jimenez M, Stannard B, Wang L-M, Pierce J, LeRoith D 1996 The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS: modulation by insulin growth factor-I (IGF-I) and enhanced IGF-I signaling. J Biol Chem 271:92879290